Certara (NASDAQ:CERT) Stock Rating Reaffirmed by Leerink Par

Certara (NASDAQ:CERT – Get Free Report)‘s stock had its “market perform” rating restated by equities research analysts at Leerink Partnrs in a research note issued on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Certara’s Q4 2023 earnings at $0.07 EPS, FY2023 earnings at $0.31 EPS, Q1 2024 earnings at $0.07 EPS, Q2 2024 […]

Related Keywords

Richardm Traynor , Leerink Partnrs , Wells Fargo Company , Advisors Asset Management Inc , Barclays , Certara Company Profile , Keycorp , Covestor Ltd , Tower Research Capital , Certara Inc , Get Free Report , Research Capital , Asset Management , Wells Fargo , Certara Daily , Certara , Nasdaq Cert , Cert , Medical , Reiterated Rating ,